Trout Capital

About us

The Trout Group has helped hundreds of public and private companies of all sizes and stages of development achieve their investor relations goals. From our headquarters in New York and offices in Boston, San Francisco, London, Shanghai and Sydney, Trout’s professionals currently serve more than 70 clients from around the world.  We provide our clients in the life sciences and energy technology sectors with expert counsel and access to the institutional investment community.

Trout Capital: Annual 1x1 Management Access Event Trout Capital: Investor Relations Excellence Trout Capital: Relationship Capital

Annual 1x1 Management Access Event

The Trout Group is pleased to announce our Annual 1x1 Management Access Event in San Francisco. More than 80 companies will be available for 1x1 meetings at this year’s event. To register, click learn more or email us at TroutSF1x1@troutgroup.com.

Learn More learn more

Investor Relations Excellence

Companies call us when they require reliable investor relations counsel and support delivered with a perspective specific to life sciences or energy technology companies. Large or small, our clients benefit from our wealth of knowledge and passion for helping.

Learn More learn more

Relationship Capital

The Trout Group is a leading investor relations and strategic advisory firm exclusively serving the life sciences and energy technology industries. Since 1996, Trout has been providing companies in the sector with access to the institutional investment community.

Learn More learn more

Conferences & Events

Download iCal

December 19, 2014 • Washington, DC, US

PDUFA: Abbvie’s ABT-267, ABT-333, and ABT-450 for HCV

Download iCal

December 23, 2014 • Washington , DC, US

PDUFA: 12/23 – BioCryst’s Rapivab for influenza

Download iCal

December 26, 2014 • Washington , DC, US

PDUFA: Actavis’ Bystolic-valsartan FDC for Systemic hypertension

Download iCal

December 26, 2014 • Washington , DC, US

PDUFA:Sun Pharmaceutical’s BAK-Free Latanoprost for Glaucoma

Download iCal

December 26, 2014 • Washington , DC, US

PDUFA: Actavis’ Bystolic-valsartan FDC for Systemic hypertension

Download iCal

December 30, 2014 • Washington , DC, US

PDUFA: POZEN’s PA8140 and PA32540 in Cardiovascular Disease

View All Events & Conferences

Our Clients

  • Photocure

    Photocure

    Norway

  • Dipexium Pharmaceuticals

    Dipexium Pharmaceuticals

    US

  • Prosensa Therapeutics B.V.

    Prosensa Therapeutics B.V.

    The Netherlands

  • NephorGenex

    NephorGenex

    US

  • Keryx Biopharmaceuticals

    Keryx Biopharmaceuticals

    US

  • Celsus Therapeutics

    Celsus Therapeutics

    US

  • Pieris AG

    Pieris AG

    Germany

  • AcelRx Pharmaceuticals, Inc.

    AcelRx Pharmaceuticals, Inc.

    US

  • Ascendis Pharma

    Ascendis Pharma

    US

  • Ekso Bionics

    Ekso Bionics

    US

  • Repros Therapeutics Inc.

    Repros Therapeutics Inc.

    US

  • Paion

    Paion

    Germany

View All Clients